Found: 2
Select item for more details and to access through your institution.
Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 1, p. 51, doi. 10.1002/art.38896
- By:
- Publication type:
- Article